Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
EXEL · against 117 other Healthcare companies of similar size
Ranked #48 of 118 · scores higher than 58% of peers
Bars: peers in each 10-point band of the growth score9 peers with a growth score of 60–69, including EXEL · Click a bar to see the companies
Mainly thanks to its earnings per share growth and 3-year revenue growth, which are stronger than most Healthcare peers.
| Metric | EXEL | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 119 reported | 9.2% | 9.9% | 47% | 33% | |
| Earnings per share growthHigher is better · 91 reported | 55.2% | 18.3% | 77% | 33% | |
| 3-year revenue growthHigher is better · 114 reported | 12.4% | 10.5% | 61% | 33% |
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 9.3B USD | 98 | 64 | |
| 2 | 14.87T KRW (≈$10.7B) | 97 | 76 | |
| 2 | 21.4B USD | 97 | 67 | |
| 4 | 16.5B USD | 96 | 37 | |
| 4 | 14.5B USD | 96 | 30 | |
| 43 | 27.8B USD | 71 | 55 | |
| 45 | 73.2B SAR (≈$19.8B) | 70 | 56 | |
| 45 | 1.21T INR (≈$14.6B) | 70 | 55 | |
| 45 | 10.6B USD | 70 | 64 | |
| 48 | 17.9B USD | 68 | 76 | |
| 48 | 34.6B USD | 68 | 58 | |
| 48 | 1.77T INR (≈$21.2B) | 68 | 57 | |
| 51 | 12.6B USD | 67 | 65 | |
| 52 | 9.3B USD | 65 | 29 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score